Oligonucleotide Synthesis Market Forecast 2025–2030: Growth Trends, Key Drivers & Future Outlook
Why Oligonucleotide Synthesis Matters in 2025 The global oligonucleotide synthesis market is entering a high-growth phase, fueled by advancements in genomics, therapeutics, and diagnostics . Valued at US$8.9 billion in 2024 , the market reached US$10.5 billion in 2025 and is expected to skyrocket to US$24.7 billion by 2030 , reflecting an impressive CAGR of 18.6% . As precision medicine, genetic testing, and RNA-based therapeutics reshape modern healthcare, the demand for high-quality synthesized oligonucleotides is accelerating worldwide. This surge underscores their pivotal role in drug discovery, disease diagnosis, and personalized treatment pathways. Download PDF Brochure: Market Growth Insights & Trends The oligonucleotide synthesis market is witnessing rapid expansion, supported by: Strong CAGR (2025–2030): 18.6% Forecasted valuation by 2030: US$24.7 billion Key industries adopting oligonucleotides: pharmaceuticals, biotech...